- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07528742
Vagus Nerve Stimulation for Reaction Time
April 9, 2026 updated by: Weiqing Ge, Youngstown State University
Enhancing Reaction Time Through Non-Invasive Vagus Nerve Stimulation
Non-Invasive Vagus Nerve Stimulation will be provided to the participants using a transcutaneous electrical nerve stimulation (TENS) unit, a routine physical therapy intervention by the faculty researcher who is a licensed physical therapist.
The electrodes will be clipped to ear over the vagus nerve distribution area.
The parameters will be 30 Hz, 250 us, 5 minutes, at tolerance (no pain).
Reaction time will test collected pre and post the stimulation using online reaction time testing platform.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Weiqing Ge Ge, DPT, PhD
- Phone Number: 330-941-2702
- Email: wge@ysu.edu
Study Locations
-
-
Ohio
-
Youngstown, Ohio, United States, 44555
- Recruiting
- Youngstown State University
-
Contact:
- Weiqing Ge, DPT, PhD
- Phone Number: 330-941-2702
- Email: wge@ysu.edu
-
Contact:
- Cathy Parrott, PhD
- Phone Number: 330 941-2559
- Email: cbieberparrott@ysu.edu
-
Principal Investigator:
- Weiqing Ge, DPT, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy participants over the age of 18
- did not receive vagus nerve stimulation previously
Exclusion Criteria:
- alcohol or drug abuse
- metal in the skull
- implanted cardiac or cranial devices
- Women during 3 trimester of pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: vagus nerve stimulation
Non-Invasive Vagus Nerve Stimulation will be provided to the participants using a transcutaneous electrical nerve stimulation (TENS) unit, a routine physical therapy intervention by the faculty researcher who is a licensed physical therapist.
The electrodes will be clipped to ear over the vagus nerve distribution area.
The parameters will be 30 Hz, 250 us, 5 minutes, at tolerance (no pain).
|
Non-Invasive Vagus Nerve Stimulation will be provided to the participants using a transcutaneous electrical nerve stimulation (TENS) unit, a routine physical therapy intervention by the faculty researcher who is a licensed physical therapist.
The electrodes will be clipped to ear over the vagus nerve distribution area.
The parameters will be 30 Hz, 250 us, 5 minutes, at tolerance (no pain)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reaction time
Time Frame: Baseline and immediately after the intervention.
|
Reaction time will test collected pre and post the stimulation using online platform.
The subjects will press a key when setting a color change in the computer screen.
|
Baseline and immediately after the intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 6, 2026
Primary Completion (Estimated)
April 5, 2027
Study Completion (Estimated)
April 5, 2027
Study Registration Dates
First Submitted
April 4, 2026
First Submitted That Met QC Criteria
April 9, 2026
First Posted (Actual)
April 14, 2026
Study Record Updates
Last Update Posted (Actual)
April 14, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026-218
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The investigators plan to present at conference and publish in scientific journal.
IPD Sharing Time Frame
One year.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects (HS)
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruitingHealthy Subjects (HS)
-
Shenyang Sunshine Pharmaceutical Co., LTD.Not yet recruitingHealthy Subjects (HS)
-
University of ManchesterRecruitingHealthy Subjects (HS)United Kingdom
-
Biotech Pharmaceutical Co., Ltd.Not yet recruitingHealthy Subjects (HS)
-
University of VigoNot yet recruiting
-
Otsuka Beijing Research InstituteOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedHealthy Subjects (HS)China
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....Recruiting
-
AkesoNot yet recruitingA Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male SubjectsHealthy Subjects (HS)China
-
Tonix Pharmaceuticals, Inc.Altasciences Company Inc.Completed
-
Bioagile Therapeutics Pvt. Ltd.Enrolling by invitation
Clinical Trials on vagus nerve stimulation
-
Northwell HealthCompletedStroke | Hemiparesis | Cerebrovascular Accident (CVA)United States
-
Beijing Municipal Administration of HospitalsRecruiting
-
Peking University People's HospitalEnrolling by invitationChemotherapy-induced Peripheral Neuropathy | CIPNChina
-
Baylor Research InstituteNational Institute of Neurological Disorders and Stroke (NINDS); University... and other collaboratorsEnrolling by invitationStroke | Ischemic Stroke | Hemorrhagic Stroke | Upper Extremity Paresis | Chronic StrokeUnited States
-
Baylor Research InstituteUniversity of Texas Southwestern Medical Center; Wings for Life; The University... and other collaboratorsActive, not recruitingSpinal Cord Injuries | Upper Extremity ParesisUnited States
-
Acacia ClinicsElectroCore INC; Vagus Nerve SocietyRecruitingPTSD | Post Traumatic Stress Disorder | Post Traumatic Stress Disorders | Post-traumatic Stress Disorder (PTSD) | Post Traumatic Stress Disorder PTSD | PTSD - Post Traumatic Stress Disorder | Post-Traumatic Stress Disorder, PTSDUnited States
-
Arpana ChurchNot yet recruitingTMD | Temporomandibular Disorders (TMDs)
-
Northwell HealthLupus Research AllianceNot yet recruitingSystemic Lupus Erythematosus
-
University Medical Centre LjubljanaCompletedIschemic Heart Disease | Arterial HypertensionSlovenia
-
University Hospital, GhentResearch Foundation FlandersCompletedEpilepsyBelgium, United States